Migdal Insurance & Financial Holdings Ltd. Vertex Pharmaceuticals Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $247,991 - $313,053	-1,401 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $109,196 - $122,199	602 Added 75.34%	1,401 $254,000
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $477,537 - $563,141	-2,547 Reduced 76.12%	799 $160,000
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $456,272 - $531,847	2,204 Added 192.99%	3,346 $677,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $236,405 - $315,294	1,142 New	1,142 $270,000
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $276,931 - $350,398	-1,823 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$167.73 - $192.74 $181,316 - $208,351	1,081 Added 145.69%	1,823 $351,000
Q2 2018 Aug 01, 2018	BUY	$145.72 - $169.96 $104,772 - $122,201	719 Added 3126.09%	742 $126,000
Q1 2018 May 02, 2018	BUY	$151.6 - $177.13 $3,486 - $4,073	23 New	23 $4,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.6 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.98 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.53 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.21 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account